Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$1.06 - $1.97 $7,156 - $13,299
6,751 Added 5.57%
127,891 $141,000
Q4 2022

Feb 14, 2023

BUY
$1.4 - $25.4 $4,193 - $76,073
2,995 Added 2.54%
121,140 $176,000
Q3 2022

Nov 14, 2022

SELL
$0.36 - $36.0 $32,311 - $3.23 Million
-89,754 Reduced 43.17%
118,145 $216,000
Q2 2022

Aug 22, 2022

BUY
$12.3 - $27.3 $776,031 - $1.72 Million
63,092 Added 43.57%
207,899 $287,000
Q1 2022

May 16, 2022

BUY
$16.6 - $32.3 $71,147 - $138,437
4,286 Added 3.05%
144,807 $374,000
Q4 2021

Feb 14, 2022

BUY
$29.9 - $61.2 $44,521 - $91,126
1,489 Added 1.07%
140,521 $420,000
Q3 2021

Nov 15, 2021

BUY
$51.4 - $68.2 $3.85 Million - $5.11 Million
74,880 Added 116.72%
139,032 $766,000
Q2 2021

Aug 12, 2021

BUY
$44.1 - $84.0 $2.83 Million - $5.39 Million
64,152 New
64,152 $470,000

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $63.8M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.